NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.97M | 2.39M | 2.89M | 5.74M | 1.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.97M | 2.39M | 2.89M | 5.74M | 1.70M |
| Cost of Revenue | 2.22M | 2.57M | 2.71M | 2.33M | 1.96M |
| Gross Profit | -242.50K | -181.50K | 178.10K | 3.41M | -267.70K |
| SG&A Expenses | 2.18M | 1.92M | 1.89M | 1.78M | 1.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 3.00M | -- |
| Total Operating Expenses | 4.40M | 4.49M | 4.60M | 7.11M | 3.58M |
| Operating Income | -2.42M | -2.10M | -1.71M | -1.37M | -1.89M |
| Income Before Tax | -2.01M | -2.09M | -1.44M | -1.62M | -1.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.01M | -2.09M | -1.44M | -1.62M | -1.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.01M | -2.09M | -1.44M | -1.62M | -1.50M |
| EBIT | -2.42M | -2.10M | -1.71M | -1.37M | -1.89M |
| EBITDA | -2.38M | -2.04M | -1.64M | -1.31M | -1.82M |
| EPS Basic | -0.23 | -0.25 | -0.17 | -0.19 | -0.19 |
| Normalized Basic EPS | -0.17 | -0.15 | -0.12 | -0.04 | -0.14 |
| EPS Diluted | -0.28 | -0.25 | -0.18 | -0.19 | -0.19 |
| Normalized Diluted EPS | -0.17 | -0.15 | -0.12 | -0.04 | -0.14 |
| Average Basic Shares Outstanding | 8.66M | 8.48M | 8.39M | 8.34M | 8.10M |
| Average Diluted Shares Outstanding | 8.74M | 8.48M | 8.39M | 8.34M | 8.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |